tirzepatide vs semaglutide for fat loss In adults with obesity but not diabetes, leads to significantly greater weight than over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Semaglutide vs. Tirzepatide for weight

Whether Mounjaro has been prescribed for diabetes management or weight loss, starting at a lower dose and increasing gradually helps ensure the safety and effectiveness of the treatment

Race reached marginal significance (P=0.046), while age and public insurance trended toward significance (P=0.05-0.08)

A., & Thieu, V

Possible side effects may include feelings of nausea, episodes of vomiting, and instances of diarrhea, relatively common but usually diminish over time

This titration process continues until you reach an effective maintenance dose, which varies from person to person based on individual metabolism and health markers